These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 28778709)

  • 1. Using multi-omics methods to understand dermatomyositis/polymyositis.
    Gao S; Luo H; Zhang H; Zuo X; Wang L; Zhu H
    Autoimmun Rev; 2017 Oct; 16(10):1044-1048. PubMed ID: 28778709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Advances in epigenetic markers of dermatomyositis/polymyositis].
    Yang YY; Zuo XX; Zhu HL; Liu SJ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Apr; 51(2):374-377. PubMed ID: 30996386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic profiling of patients with different idiopathic inflammatory myopathy subtypes reveals potential biomarkers in plasma.
    Zhao Q; Hu Q; Meng S; Zhang Q; Wang T; Liu C; Liu D; Jiang Z; Hong X
    Clin Exp Med; 2023 Nov; 23(7):3417-3429. PubMed ID: 37103652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Idiopathic inflammatory myopathies.
    Dimachkie MM; Barohn RJ
    Semin Neurol; 2012 Jul; 32(3):227-36. PubMed ID: 23117947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dermatomyositis and polymyositis: from immunopathology to immunotherapy (immunobiologics).
    Shinjo SK; de Souza FH; de Moraes JC
    Rev Bras Reumatol; 2013 Feb; 53(1):101-10. PubMed ID: 23588520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recent research developments in polymyositis/dermatomyositis].
    Okiyama N; Kohsaka H
    Nihon Rinsho Meneki Gakkai Kaishi; 2008 Apr; 31(2):85-92. PubMed ID: 18446010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intravenous immunoglobulins in polymyositis and dermatomyositis].
    Chérin P; Herson S
    Rev Med Interne; 1999; 20 Suppl 4():436s-439s. PubMed ID: 10522319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Idiopathic inflammatory myopathies: main clinical and immunological variants, difficulties of differential diagnostics and therapy].
    Antelava OA; Nasonov EL
    Klin Med (Mosk); 2014; 92(3):19-25. PubMed ID: 25269190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The possible role of physical exercise on the treatment of idiopathic inflammatory myopathies.
    de Salles Painelli V; Gualano B; Artioli GG; de Sá Pinto AL; Bonfá E; Lancha Junior AH; Lima FR
    Autoimmun Rev; 2009 Mar; 8(5):355-9. PubMed ID: 19041955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated comparison of the miRNAome and mRNAome in muscles of dermatomyositis and polymyositis reveals common and specific miRNA-mRNAs.
    Gao S; Zhang H; Zuo X; Xiao Y; Liu D; Zhu H; Luo H
    Epigenomics; 2019 Jan; 11(1):23-33. PubMed ID: 30523707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review article: a therapeutic update on dermatomyositis/polymyositis.
    Ghate J; Katsambas A; Augerinou G; Jorizzo JL
    Int J Dermatol; 2000 Feb; 39(2):81-7. PubMed ID: 10692055
    [No Abstract]   [Full Text] [Related]  

  • 12. Idiopathic inflammatory myopathy: clinicopathological observations in the Indian population.
    Prasad ML; Sarkar C; Roy S; Bagchi U; Singh RR; Singh YN; Sharma S; Malaviya AN
    Br J Rheumatol; 1992 Dec; 31(12):835-9. PubMed ID: 1458290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of inflammatory myopathies.
    Pipitone N; Salvarani C
    Expert Rev Clin Immunol; 2018 Jul; 14(7):607-621. PubMed ID: 29952659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune mechanisms in polymyositis and dermatomyositis and potential targets for therapy.
    Venalis P; Lundberg IE
    Rheumatology (Oxford); 2014 Mar; 53(3):397-405. PubMed ID: 23970542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dermatomyositis and polymyositis].
    Pellissier JF; Civatte M; Fernandez C; Bartoli C; Chetaille B; Schleinitz N; Figarella-Branger D
    Rev Neurol (Paris); 2002 Oct; 158(10 Pt 1):934-47. PubMed ID: 12407302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibodies in adult patients with idiopathic inflammatory myopathies in Buenos Aires.
    Gómez GN; Gargiulo Mde L; Pérez N; Collado MV; Suárez LV; Khoury M; Sarano JF
    Medicina (B Aires); 2016; 76(3):129-34. PubMed ID: 27295700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunopathology and treatment of polymyositis and dermatomyositis].
    Hase A; Arahata K
    Nihon Naika Gakkai Zasshi; 1998 Apr; 87(4):664-9. PubMed ID: 9627475
    [No Abstract]   [Full Text] [Related]  

  • 18. The expression of cyclooxygenase-1, cyclooxygenase-2 and 5-lipoxygenase in inflammatory muscle tissue of patients with polymyositis and dermatomyositis.
    Studýnková JT; Kuchen S; Jeisy E; Schedel J; Charvát F; Jarosová K; Sprott H; Matucci-Cerinic M; Gay RE; Michel BA; Pavelka K; Vencovský J; Gay S
    Clin Exp Rheumatol; 2004; 22(4):395-402. PubMed ID: 15301234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hospitalization mortality and associated risk factors in patients with polymyositis and dermatomyositis: A retrospective case-control study.
    Wu C; Wang Q; He L; Yang E; Zeng X
    PLoS One; 2018; 13(2):e0192491. PubMed ID: 29474373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dermatomyositis and polymyositis: new treatment targets on the horizon.
    Hak AE; de Paepe B; de Bleecker JL; Tak PP; de Visser M
    Neth J Med; 2011 Oct; 69(10):410-21. PubMed ID: 22058260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.